Pain can be widespread or associated with a separate local concern. Illustrative photograph, not a diagnosis of fibromyalgia or a clinic treatment result.
Pain in several parts of the body can be exhausting, particularly when sleep is unrefreshing and ordinary activities take more effort than they used to. Fibromyalgia is one possible explanation for persistent widespread pain. It is a recognised condition, and a normal scan or routine blood test does not make the pain less real.
For someone considering platelet-rich plasma, the distinction between widespread pain and a specific tendon or joint problem matters. PRP is a treatment directed at a selected tissue or structure. It should not be presented as an established treatment for fibromyalgia or as a way to reset pain throughout the body. A useful assessment first clarifies the symptom pattern and whether a separate local condition is also present.
What is fibromyalgia?
Fibromyalgia is a condition associated with widespread pain and a range of other symptoms, including fatigue, poor sleep and difficulties with concentration. NICE includes fibromyalgia within chronic primary pain. That term does not mean imagined pain, minor pain or pain that someone should be able to overcome through willpower.
Chronic pain is pain that persists or recurs for more than three months. In chronic primary pain, an underlying condition does not adequately explain the pain or its impact. Pain processing is complex, and the explanation is not simply that every painful area contains an injury that needs repairing.
This matters when considering an injection. A procedure that targets a particular tendon cannot automatically be expected to change a widespread pain condition. The diagnosis, the intended treatment target and the outcome being discussed need to match. Otherwise an apparently precise treatment can be offered without a clear clinical purpose.
Which symptoms can occur alongside pain?
The NHS describes aching, burning or sharp pain that may be widespread but worse in some areas. Increased sensitivity can mean that a light touch feels painful or a minor injury hurts for longer than expected. Stiffness can also be prominent, particularly after remaining in one position.
Fatigue is often more than ordinary tiredness. Sleep may not feel restorative, even when someone has spent enough time in bed. Some people describe difficulties remembering, concentrating or thinking clearly, often called fibro-fog. Headaches and irritable bowel symptoms can occur alongside the pain as well.
These features are useful for a clinical history, but a collection of symptoms on a webpage cannot establish the diagnosis. Several conditions can overlap, and a person may have more than one explanation for their symptoms. The assessment considers the whole pattern rather than relying on a single symptom or a checklist completed without discussion.
How is the diagnosis made?
There is no single blood test or scan that confirms fibromyalgia. The NHS advises seeing a GP if the condition is suspected. A clinician considers the nature, distribution and duration of symptoms, their effect on daily life and whether the history or examination suggests another condition.
Examination can help identify findings that need a different investigation route. For example, visibly swollen joints may suggest an inflammatory joint condition rather than being explained by fibromyalgia alone. The clinician may arrange selected tests to investigate other possible causes when the findings indicate that these would be useful.
A diagnosis should provide an explanation and a plan, not close down further care. NICE recognises that an initial chronic primary pain diagnosis can change with time. If the presentation changes, the diagnosis should be reassessed. Someone with established fibromyalgia remains entitled to an assessment of a genuinely new symptom.
Can fibromyalgia coexist with arthritis or a tendon problem?
Yes. NICE specifically recognises that chronic primary pain and chronic secondary pain can coexist. A person may have fibromyalgia and a separate condition that explains pain in one particular area. Identifying one diagnosis does not automatically remove the other, nor does every local ache necessarily represent a second injury.
The practical task is to separate the questions. Widespread pain, fatigue and unrefreshing sleep need a broader management plan. A clearly localised problem, such as pain related to loading a particular tendon, may need a focused assessment. The findings determine whether there is a separate diagnosis and whether it changes treatment.
For PRP, this distinction protects realistic expectations. Even if an injection is considered for an appropriately assessed local condition, it is not a treatment for all pain experienced by that person. Any discussion of likely benefit should identify the particular symptom and activity being targeted rather than promising a global recovery.
Why do normal tests not invalidate the pain?
Tests answer particular questions. A blood test may help investigate thyroid function or another suspected condition, while imaging can assess a selected structure. They do not directly measure every part of the experience of pain. Normal findings may therefore be useful without explaining why the symptoms feel so severe.
NICE advises sensitivity when communicating normal or negative results because the explanation can otherwise leave someone feeling dismissed. Reassurance is more helpful when it states what the test has assessed, what remains uncertain and how the clinical plan follows from the overall picture.
Repeated investigations are not automatically better care, but neither is stopping the assessment simply because an earlier result was normal. The decision depends on the current symptoms and findings. A meaningful plan recognises the pain, avoids unnecessary procedures and provides a route to review if something changes.
What does a useful pain assessment cover?
A careful assessment includes the pain itself and the effect it has on daily life. Sleep, work, physical activity, emotional wellbeing and relationships can all be affected. NICE recommends a person-centred discussion that also considers what already helps, the person's strengths and their priorities for care.
This is not an exercise in attributing pain to stress or asking someone to justify their symptoms. Physical and emotional factors can influence each other in any long-term condition. Understanding that context can help make a treatment plan more tolerable and practical without suggesting that the pain is voluntary.
Goals may include sleeping more consistently, managing a particular daily activity or returning gradually to a valued form of movement. They should be agreed with the individual. A plan based only on a pain score can miss improvements that matter, while a promise of complete pain removal may create an expectation the evidence does not support.
Where does physical activity fit?
The NHS identifies exercise as one of the main treatments for fibromyalgia. NICE recommends a supervised group exercise programme for chronic primary pain, taking account of needs, preferences and abilities, and encourages continued physical activity for longer-term health. This is a treatment discussion, not a test of motivation.
Pain and fatigue can make activity difficult. The starting point, type of movement and support need to fit the individual rather than follow a rigid programme chosen from an article. An activity that is enjoyable and can be maintained is more useful than an ambitious schedule that repeatedly feels unmanageable.
Advice should allow for fluctuating symptoms and other health conditions. A person should not assume that every new symptom is an expected response to exercise or that they must force through a new injury. The clinical plan can be reviewed when the pattern changes or the proposed activity is not workable.
Why might a talking therapy help a physical pain condition?
NICE recommends considering acceptance and commitment therapy or cognitive behavioural therapy for chronic primary pain when delivered by appropriately trained healthcare professionals. The NHS also describes these approaches as options for fibromyalgia. They can support coping, sleep and quality of life while addressing the impact of persistent pain.
Offering a talking therapy does not mean that a clinician thinks the pain is imagined. These approaches can be part of care for a genuine physical experience. The explanation should make clear what the therapy aims to help with and how it fits alongside other elements of the plan.
Different people have different preferences and previous experiences of treatment. A useful discussion allows those to shape the choice. It should not imply that accepting psychological support is a condition for being believed or receiving an assessment of a separate joint or tendon concern.
What role can medicines have?
Some antidepressant medicines may be considered for chronic primary pain after a discussion of benefits and harms. NICE explains that they may help pain, sleep, quality of life and psychological distress even when depression is not diagnosed. Their use for pain should be explained rather than leaving someone to infer the reason from the drug name.
The choice depends on the person's circumstances, other medicines, possible side effects and preferences. It is not appropriate to choose a drug or dose from a general article. The NHS notes that no single treatment works for every symptom and that a combination of approaches may be needed.
Medicines already being taken also deserve review. NICE distinguishes decisions about starting treatment from decisions about continuing or reducing an existing prescription. Do not suddenly stop an antidepressant, opioid, gabapentinoid or another medicine because of a general recommendation. Withdrawal and the reason for the original prescription need an individual plan.
Why are routine painkillers not a universal answer?
NICE advises against starting several medicines specifically to manage chronic primary pain, including opioids, gabapentinoids, non-steroidal anti-inflammatory drugs and paracetamol. This guidance reflects the evidence and the balance of benefit and harm for chronic primary pain. It is not a statement that those medicines never have a role for any other diagnosis.
That distinction matters for someone who has more than one condition. Treatment for a separate injury or another cause of pain may follow different guidance. A clinician reviews what each medicine is intended to treat rather than assuming one recommendation applies equally to every symptom.
Where an existing medicine provides little benefit or causes harm, a supported change may be appropriate. Where someone reports benefit at a safe dose with few harms, NICE recommends a shared review rather than automatic withdrawal. A careful medicines discussion should reduce uncertainty, not leave someone to alter several prescriptions alone.
What is PRP intended to do?
PRP is prepared from a person's own blood by separating a platelet-rich portion. In musculoskeletal care it is used as an injection directed at a selected tissue. The clinical question concerns the specific diagnosis, preparation, injection target, alternatives and evidence, not simply whether blood-derived growth factors can be found in the preparation.
The hospital information cited below describes a tendon injection pathway. It should not be read as evidence that PRP treats fibromyalgia, nor as a description of this clinic's preparation, medicines advice or follow-up arrangements. Instructions can differ between services and must come from the treating clinician.
Using someone's own blood does not make an injection automatically effective or risk-free. The expected benefit, uncertainty, discomfort, bleeding, infection and possible lack of improvement need consideration within an individual treatment discussion. Consent should be about a defined treatment for a defined problem, not a general promise of regeneration.
Why should PRP not be sold as a fibromyalgia treatment?
The NICE chronic primary pain guideline and NHS fibromyalgia guidance cited here do not establish PRP as a recommended treatment for fibromyalgia. Their management approaches centre on an individual plan that can include activity, psychological therapy and selected medicines. A local injection should not be substituted for that broader care without a sound indication.
Evidence for a treatment in one condition cannot simply be transferred to another. A study of a tendon or knee condition does not demonstrate benefit for widespread fibromyalgia symptoms. Equally, laboratory descriptions of platelets and growth factors do not establish that injecting them will change sleep, fatigue or pain processing throughout the body.
Even for tendinopathy, NICE's guidance on autologous blood injections, including approaches that produce PRP, describes uncertainty about efficacy and calls for special governance, consent and audit or research arrangements. That is a reason for a measured, diagnosis-specific discussion, not a basis for expanding treatment claims to unrelated pain conditions.
When might a separate local treatment discussion be reasonable?
A focused discussion may be appropriate if assessment identifies a separate local condition with its own treatment options. The clinician should be able to explain why that area is being considered, what has already been tried and what uncertainty remains. Persistent pain alone is not enough to establish an injection target.
The decision should compare relevant alternatives and the likely benefit for that particular problem. It should also account for the wider pain condition when agreeing goals. Treating one structure may not resolve all tenderness, fatigue or activity limitations, so the broader care plan still matters.
An enquiry with The London PRP Clinic can clarify whether a local joint or tendon concern is appropriate for its assessment route. It does not confirm that PRP will be recommended, that a diagnosis has been established remotely or that the clinic provides a dedicated fibromyalgia service. A GP-led assessment remains important for widespread or unexplained symptoms.
What should happen when symptoms flare or change?
Symptoms can fluctuate, and NICE recommends reassessment when a person presents with a flare-up or change in chronic pain. The review can consider new symptoms, possible contributors and whether the existing care plan remains suitable. Sometimes no clear cause for the flare is identified, but the experience still deserves attention.
A previous fibromyalgia diagnosis should not be used to dismiss an acutely unwell person or a new neurological, breathing or chest symptom. Urgent symptoms need the appropriate urgent or emergency service rather than waiting for a PRP enquiry. A routine injection appointment is not a substitute for assessment of a new serious problem.
For non-emergency changes, the review may revisit activity, sleep, medicines and the original diagnostic reasoning. The aim is neither to assume that everything is a flare nor to start the entire investigation process again automatically. It is to respond to the current presentation with a clear clinical explanation and next step.
Discussing a local joint or tendon concern
If you have fibromyalgia and a separate local joint or tendon concern, The London PRP Clinic can receive an enquiry about assessment suitability. Include where the local pain is, how long it has been present, any established diagnosis and previous treatment. Explain that widespread symptoms are also part of the picture.
The purpose is to clarify the appropriate route, not to promise PRP for fibromyalgia or a particular treatment outcome. An honest discussion may conclude that another assessment or continued broader pain management is more appropriate. The value lies in choosing care that matches the condition, including when an injection is not the right next step.
Discuss a local joint or tendon concern and assessment suitability
Frequently asked questions
Is fibromyalgia a real condition if my tests are normal?
Yes. Fibromyalgia is a recognised condition, and there is no single test that confirms it. Normal findings do not invalidate the pain. The diagnosis depends on clinical assessment, and selected tests may be used to investigate other possible causes or coexisting conditions.
Can PRP treat widespread fibromyalgia pain?
PRP should not be presented as an established treatment for fibromyalgia. Guidance cited here does not support transferring evidence from local tendon or joint treatments to widespread pain, fatigue or sleep symptoms. Those concerns need an individual broader management plan.
Can I have fibromyalgia and a separate tendon problem?
Yes. Chronic primary and secondary pain can coexist. A focused assessment may identify a separate local condition, but every painful area is not necessarily a new injury. Any proposed local treatment should have a clear diagnosis, target and realistic goal.
Why might an antidepressant be discussed if I am not depressed?
Some antidepressants may help chronic primary pain, sleep or quality of life even without depression. A clinician should explain the intended benefit and possible harms before prescribing. The choice and dose need an individual review rather than self-treatment.
Should I stop my current pain medicines?
Do not stop prescribed medicines suddenly because of an article. NICE recommends a shared review of benefits and harms, with a supported plan where a change is appropriate. Withdrawal effects and treatment for any separate condition also need consideration.
Should a new symptom always be treated as a fibromyalgia flare?
No. New symptoms may need reassessment, and urgent symptoms need the appropriate urgent or emergency service. An established diagnosis does not exclude another illness or injury. A PRP enquiry should not delay care for an acute or concerning change.
Sources
NICE, Chronic pain: assessment and management, NG193 recommendations
Hospital information, PRP blood injection
NICE, Autologous blood injection for tendinopathy, HTG299 recommendations